KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Exchange Rate Effect (2016 - 2025)

Emergent BioSolutions (EBS) has 15 years of Exchange Rate Effect data on record, last reported at -$200000.0 in Q3 2025.

  • For Q3 2025, Exchange Rate Effect changed N/A year-over-year to -$200000.0; the TTM value through Dec 2025 reached $100000.0, changed N/A, while the annual FY2025 figure was $100000.0, N/A changed from the prior year.
  • Exchange Rate Effect reached -$200000.0 in Q3 2025 per EBS's latest filing, down from $1.0 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2022 and bottomed at -$1.5 million in Q4 2023.
  • Average Exchange Rate Effect over 4 years is -$64285.7, with a median of -$200000.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: tumbled 400.0% in 2021, then skyrocketed 250.0% in 2022.
  • A 4-year view of Exchange Rate Effect shows it stood at -$200000.0 in 2021, then surged by 650.0% to $1.1 million in 2022, then crashed by 236.36% to -$1.5 million in 2023, then skyrocketed by 86.67% to -$200000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were -$200000.0 in Q3 2025, $1.0 million in Q2 2025, and -$700000.0 in Q1 2025.